Health and Medicine
Humans are each home to trillions of microbes that have a widespread impact on our physiology and predisposition to disease. Peter Turnbaugh, PhD, Assistant Professor, Department of Microbiology and Immunology, UCSF, explains. Recorded on 12/10/2015.
Antibiotics can save lives but they also have unintended consequences, add unnecessary costs to treatment and can have adverse effects. Recorded on 03/01/2016.
Americans constitute 4.6% of the world's population and consume 80% of the world's opioids and 99% of the world's hydrocodone. There are five times more Americans with opioid substance use disorder than addicted to heroin. How did we get here and what can we do about it? Recorded on 03/17/2016.
Trauma injuries affect millions in the the global community every year. Hear from orthopoaedic surgeons who lead surgical missions and use the power of surgical education to save limbs and save lives in the developing world. Recorded on 06/14/2016.
From neuropathology to molecular target to clinical treatments, where are we on the road to finding an effective treatment for Alzheimer's disease? Howard Feldman, MD, FRCP(C), a neurologist noted for his original research in geriatric cognitive disorders and expertise in large-scale clinical trials, walks through the latest research and shares some tips on brain health.
In his new book, Spitting in the Soup: Inside the Dirty Game of Doping in Sports, UC San Diego alumnus and sports journalist Mark Johnson traces the doping culture in professional sports, from the early days when pills meant progress, to the current day, when athletes are vilified for the use of performance-enhancing drugs. In his book, Johnson, who has covered cycling as a writer and photographer since the 1980s, explores the complex relationships that underlie elite sports culture.
For the past three decades the largest family in the world with a genetic form of Alzheimer's disease has been tracked. This extended family of some 5,000 individuals live in Antioquia, Colombia among a people who call themselves Paisa. Passing relentlessly through the generations with 100% penetrance is a mutation that causes early onset Alzheimer's disease in its carriers. Dr. Kenneth Kosik explains that the mutation in the Americas likely originated from a Spanish conquistador whose progeny are the members of the family we see today. Recently, interest in the family has grown because they are now participating in a clinical trial intended to delay the onset of the disease. Recorded on 06/30/2016.
Rupert Spira, author of "The Transparency of Things," speaks here with Paul J. Mills of UC San Diego about the concept of non-duality, or advaita. They explore the idea that there is no separation between the self and the universe -- and how understanding this basic truth will lead to greater wellbeing.
Drs. Clement Yeh and Rachael Callcut reflect on the response to the deadly Asiana Airlines Flight 214 crash at San Francisco International Airport. Yeh, an emergency physician at San Francisco General Hospital, and Callcut, the backup surgeon at the hospital the day of the crash, were among those treating patients. Recorded on 10/20/2016.
Traumatic brain injury results from an impact to the head that disrupts normal brain function. Dr. Phiroz Tarapore looks at strategies for treating patients with chronic traumatic brain injury. Recorded on 11/03/2016.
J. Craig Venter, founder, chair and CEO of the J. Craig Venter Institute and co-founder of two private genomics companies, recounts his breakthroughs in genome sequencing and shares new research on fighting cancer tumors with personalized vaccines. Venter is presented by the Altman Clinical and Translational Research Institute at UC San Diego.
Itchy misery: Hives / Hives: Causes and triggers / Cold that gets under your skin / Foods that truly lower cholesterol / Tips for swollen legs / Cycling: Get it right!
As baby boomers age, an unprecedented number of people will be diagnosed with Alzheimer's disease. The economic and social impacts will be wide reaching from cost of treatment to the effect on caregivers. Maria Carrillo, PhD, Chief Science Officer, Alzheimer's Association joins Willliam Mobley. MD, PhD to discuss what can be done and how government, industry and the Alzheimer's Association are working together on larger scale trials and innovative projects. Recorded on 12/8/2016.